Trials / Completed
CompletedNCT00503217
GnRH Agonist and Intrauterine Insemination
Effect of GnRH Agonist Administration at the Time of Implantation in Intrauterine Insemination Cycles: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tryptorelin |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2007-07-18
- Last updated
- 2016-09-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00503217. Inclusion in this directory is not an endorsement.